Angiosarcoma is an aggressive malignancy derived from endothelial cells, characterised by its rapid progression, heterogeneity and distinct clinical challenges. As a subset of soft tissue sarcomas, ...

Paclitaxel remains first-line for cutaneous angiosarcoma, but absence of validated second-line therapy creates a major unmet need after progression or intolerance. A 30-patient, 15-center JCOG study ...

Epidemiological trends and socioeconomic factors in malignant peripheral nerve sheath tumors with rhabdomyoblastic differentiation: A National Cancer Database study. This is an ASCO Meeting Abstract ...

Angiosarcoma of the liver is a rare, aggressive form of cancer that develops in the cells involved in immune system response. It accounts for about 0.1–2% of all liver cancers, but is the third most ...

Seven years after completing breast cancer treatment, Angelia Carpenter was shocked to discover she had angiosarcoma, a rare cancer that may have been associated with her breast cancer treatment. When ...